<DOC>
	<DOCNO>NCT00358124</DOCNO>
	<brief_summary>To compare glycemic control , measure HbA1C , insulin glargine rosiglitazone add-on therapy patient fail oral combination sulfonylurea metformin</brief_summary>
	<brief_title>Insulin Glargine v Rosiglitazone add-on Therapy Patients Failing Sulfonylurea Metformin Combination Therapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>INCLUSION CRITERIA : Diagnosis type 2 diabetes mellitus least one year ; Continuous treatment least half maximally label dose sulfonylurea least 1000 mg metformin daily least three month ; Glycated hemoglobin 7.5 11 % unit , inclusive ; Willingness accept , ability inject insulin glargine therapy EXCLUSION CRITERIA : Stroke , MI , coronary artery bypass graft , percutaneous transluminal coronary angioplasty angina pectoris within last 12 month ; Congestive heart failure require pharmacological treatment ; Serum creatinine &gt; 1.5 mg/dl male , &gt; 1.4 mg/dl female ; Acute chronic metabolic acidosis , include diabetic ketoacidosis ; Planned radiological examination require administration contrast agent ; Clinical evidence active liver disease , serum ALT 2.5 time upper limit normal range ; History hypoglycemia unawareness ; Pregnancy lactation ; Failure use adequate contraception ( woman current reproductive potential ) ; Known hypersensitivity insulin glargine , rosiglitazone component insulin glargine rosiglitazone ; BMI &gt; 25 kg/m2 ; Malignancy except basal cell carcinoma within last five year ; History substance alcohol abuse within last two year , current addiction substance alcohol abuse ; Any disease condition opinion investigator and/or sponsor may interfere completion study ; Incapability comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>